The regulation of IL-12: Its role in infectious, autoimmune, and allergic diseases

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 1, 1998, Pages 11-15

  McDyer, John F ^a   Wu, Chang You ^a   Seder, Robert A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ALLERGIC DISEASE; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0031845998     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70047-8     Document Type: Article

References (34)

1. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-76.
2. Seder RA, Kelsall BL, Jankovic D. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 1996;157:2745-8.
3. Gavett SH, O'Hearn DJ, Li X, Huang S, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-36.
4. d'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. IL-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.
5. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, et al. The interleukin 12 p40 gene promoter is primed by IFN-γ in monocytic cells. J Exp Med 1996;183:147-57.
6. Hayes MP, Wang J, Norcross MA. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 1995;86:646-50.
7. Flesch IEA, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H, et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon-γ and tumor necrosis factor-α. J Exp Med 1995;181:1615-21.
8. Szalay G, Ladel CH, Blum C, Kaufmann SHE. IL-4 neutralization or TNF-α treatment ameliorate disease by an intracellular pathogen in IFN-γ receptor-deficient mice. J Immunol 1996;157:4746-50.
9. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, et al. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 1996;157:4045-54.
10. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178:669-74.
11. deKruyff RH, Gieni RS, Umetsu DT. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. J Immunol 1997;158:359-66.
12. Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, et al. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996;26:370-8.
13. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, et al. Activated T cells induced interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995;25:1125-8.
14. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52.
15. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T cell priming in mice lacking CD40 ligand [letter]. Nature 1995;348:617-20.
16. van Essen D, Kikutani H, Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function [letter]. Nature 1995;378:620-3.
17. Grewal IS, Flavell RA. The role of CD40 ligand in costimulation and T cell activation. Immunol Rev 1996;153:85-106.
18. Zhou P, Seder RA. CD40 ligand is not essential for induction of Type 1 cytokine responses or protective immunity following primary or secondary infection with Histoplasma capsulatum. J Exp Med 1998 In press.
19. Campos-Neto A, Ovendale P, Bernent T, Koppi TA, Fanslow WC, Rossi MA, et al. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 1998;160:2037-41.
20. Sousa CR, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 1997;186:1819-29.
21. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 1995;96:2339-47.
22. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J Immunol 1996;157:798-804.
23. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amegaza M, et al. Interleukin-12 primes human CD4 and CDS T cell clones for high production of both IFN-γ and IL-10. J Exp Med 1996;183:2559-69.
24. Jeannin P, Delneste Y, Seveso M, Life P, Bonnefoy JY. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol 1996;156:3159-65.
25. Chehimi J, Starr SE, Frank I, d'Andrea A, Ma X, MacGregor RR, et al. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-6.
26. Chougnet C, Wynn TA, Clerici M, Landay AL, Kessler HA, Rusnak J, et al. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996;174:46-53.
27. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996;273:228-31.
28. Marth T, Kelsall BL. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 1997;185:1987-95.
29. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Müller W, Kühn R, et al. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996;183:515-26.
30. van der Pouw Kraan TCTM, Boeije LCM, Smeenk RJT, Wijdenes J, Aarden LA. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995;181:775-9.
31. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott-P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-7.
32. Gurunathan S, Sacks DL, Brown DR, Reiner SL, Charest H, Glaichenhaus N, et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med 1997;186:1137-47.
33. 1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996;93:5141-5.
34. Hsu C-H, Chua K-Y, Tao M-H, Lai Y-L, Wu H-D, Huang SK, et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nature Med 1996;2:540-4.